Labo'life
Clinical trials sponsored by Labo'life, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A 20-Year-Old immune regulator faces its biggest test against cold sores Results expected Mar 2027 (estimated)
-
A new attack on Epstein-Barr fatigue: two capsules put to the test
Disease control Recruiting nowThis trial tests whether two experimental capsules, 2LEBV and 2LXFS, can reduce fatigue and other symptoms in people with an Epstein-Barr virus infection. Participants take one capsule daily for six months, either one of the study drugs or a placebo. The study measures changes in…
Phase 4 • Sponsor: Labo'Life • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
A pill that fights warts from the inside: trial puts immune-regulating capsule to the test
Disease control Recruiting nowThis trial tests whether a daily oral capsule called 2LVERU can clear common, flat, or plantar warts caused by HPV. Researchers compare the capsule against a placebo in 162 people aged 3 and older over 6 months. The main question is whether warts disappear completely by the end o…
Phase 4 • Sponsor: Labo'Life • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
A 20-Year-Old immune regulator faces its biggest test against cold sores
Disease control Recruiting nowThis trial tests whether 2LHERP, an immune regulator available for over 20 years, can reduce the number of cold sore outbreaks in adults who get at least six per year. Participants take one capsule daily for six months, then researchers compare outbreak rates over a year against …
Phase 4 • Sponsor: Labo'Life • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
A 20-Year-Old immune regulator faces its biggest test against HPV
Disease control Recruiting nowThis trial tests whether 2LPAPI, an immune regulator used for over 20 years, can help clear high-risk genital HPV infections faster than a placebo. Researchers will enroll 284 women aged 25 to 45 with a current high-risk HPV diagnosis. Participants receive either 2LPAPI or a plac…
Phase 4 • Sponsor: Labo'Life • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC